Figure 2.
Figure 2. Increased cell surface expression of CD63 and reduced elastase levels in HPS2 patients. (A) Circulating neutrophils were separated as described in “Patients, materials, and methods,” washed twice, and analyzed by a flow cytometer for expression of CD63. CD63 staining (thick line) in comparison with mouse IgG antibody (thin line) is presented on a histogram plot. Red fluorescence intensity is shown on the x-axis expressed in a log scale; the number of cells per channel is shown on the y-axis. Experiment shown is representative of 3 independent experiments performed. (B) Immunofluorescence staining for NE in circulating neutrophils from HPS2 patients. PMN cells were obtained from peripheral blood, cytocentrifuged, and stained with anti-NE. In cells from a control subject, a strong expression of NE is observed in the cytoplasm with the presence of cytoplasmic dots (top panel). In patients (Pt 1 and Pt 2), only scattered NE-positive dots are evident (middle and bottom panels) in rare PMN cells. NE was revealed using FITC-conjugated secondary antibody. Experiment shown is representative of 2 performed. (C) Western blot analysis for NE in circulating neutrophil content for HPS2 patients. Cell lysates from separated neutrophils of Pt 1, Pt 2, their father, and a healthy control were separated by SDS-PAGE and probed with NE antibody (see “Patients, materials, and methods”). β-actin was used to compare protein levels. (D) Confocal microscopy analysis of double immunofluorescence staining of PMN cells from HPS Pt 1 with antielastase (green) and anti-CD43 (red) was performed as described in “Patients, materials, and methods.” Experiment shown is representative of 2 performed. Sections were examined using an Olympus BX60 fluorescence microscope and objectives with numeric apertures of 0.40 (10 ×), 0.70 (20 ×), 0.85 (40 ×), and 0.90 (60 ×), equipped with a DP-70 Olympus digital camera (Olympus, Melville, NY). Images were acquired using analySIS Image Processing software (Soft Imaging System, Münster, Germany).

Increased cell surface expression of CD63 and reduced elastase levels in HPS2 patients. (A) Circulating neutrophils were separated as described in “Patients, materials, and methods,” washed twice, and analyzed by a flow cytometer for expression of CD63. CD63 staining (thick line) in comparison with mouse IgG antibody (thin line) is presented on a histogram plot. Red fluorescence intensity is shown on the x-axis expressed in a log scale; the number of cells per channel is shown on the y-axis. Experiment shown is representative of 3 independent experiments performed. (B) Immunofluorescence staining for NE in circulating neutrophils from HPS2 patients. PMN cells were obtained from peripheral blood, cytocentrifuged, and stained with anti-NE. In cells from a control subject, a strong expression of NE is observed in the cytoplasm with the presence of cytoplasmic dots (top panel). In patients (Pt 1 and Pt 2), only scattered NE-positive dots are evident (middle and bottom panels) in rare PMN cells. NE was revealed using FITC-conjugated secondary antibody. Experiment shown is representative of 2 performed. (C) Western blot analysis for NE in circulating neutrophil content for HPS2 patients. Cell lysates from separated neutrophils of Pt 1, Pt 2, their father, and a healthy control were separated by SDS-PAGE and probed with NE antibody (see “Patients, materials, and methods”). β-actin was used to compare protein levels. (D) Confocal microscopy analysis of double immunofluorescence staining of PMN cells from HPS Pt 1 with antielastase (green) and anti-CD43 (red) was performed as described in “Patients, materials, and methods.” Experiment shown is representative of 2 performed. Sections were examined using an Olympus BX60 fluorescence microscope and objectives with numeric apertures of 0.40 (10 ×), 0.70 (20 ×), 0.85 (40 ×), and 0.90 (60 ×), equipped with a DP-70 Olympus digital camera (Olympus, Melville, NY). Images were acquired using analySIS Image Processing software (Soft Imaging System, Münster, Germany).

Close Modal

or Create an Account

Close Modal
Close Modal